RNC Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $33.2M | Sell |
616,326
-46,351
| -7% | -$2.23M | 1.51% | 33 |
|
|
2025
Q3 | $29.9M | Sell |
662,677
-38,618
| -6% | -$1.8M | 1.37% | 35 |
|
|
2025
Q2 | $32.5M | Sell |
701,295
-12,659
| -2% | -$621K | 1.57% | 32 |
|
|
2025
Q1 | $43.5M | Buy |
713,954
+24,119
| +3% | +$1.41M | 2.22% | 18 |
|
|
2024
Q4 | $39M | Sell |
689,835
-49,297
| -7% | -$2.75M | 2.08% | 22 |
|
|
2024
Q3 | $30.7M | Hold |
739,132
| – | – | 1.7% | 31 |
|
|
2024
Q2 | $30.7M | Buy |
739,132
+20,680
| +3% | +$925K | 1.7% | 31 |
|
|
2024
Q1 | $39M | Buy |
718,452
+59,250
| +9% | +$3.02M | 2.22% | 22 |
|
|
2023
Q4 | $33.8M | Sell |
659,202
-157,502
| -19% | -$8.27M | 2.03% | 25 |
|
|
2023
Q3 | $47.4M | Sell |
816,704
-116,710
| -13% | -$7.15M | 2.94% | 11 |
|
|
2023
Q2 | $59.7M | Sell |
933,414
-25,960
| -3% | -$1.74M | 3.3% | 4 |
|
|
2023
Q1 | $66.5M | Sell |
959,374
-9,173
| -0.9% | -$647K | 3.75% | 3 |
|
|
2022
Q4 | $69.7M | Buy |
968,547
+11,634
| +1% | +$877K | 3.9% | 2 |
|
|
2022
Q3 | $68M | Sell |
956,913
-8,207
| -0.9% | -$595K | 4.27% | 1 |
|
|
2022
Q2 | $74.3M | Buy |
965,120
+19,129
| +2% | +$1.46M | 4.23% | 1 |
|
|
2022
Q1 | $69.1M | Sell |
945,991
-99,760
| -10% | -$6.7M | 3.51% | 3 |
|
|
2021
Q4 | $65.2M | Buy |
1,045,751
+110,252
| +12% | +$6.47M | 3.23% | 7 |
|
|
2021
Q3 | $55.4M | Buy |
935,499
+3,154
| +0.3% | +$208K | 2.94% | 7 |
|
|
2021
Q2 | $62.3M | Buy |
932,345
+165,001
| +22% | +$10.8M | 3.3% | 6 |
|
|
2021
Q1 | $48.4M | Buy |
767,344
+19,045
| +3% | +$1.18M | 2.74% | 11 |
|
|
2020
Q4 | $46.4M | Buy |
748,299
+6,497
| +0.9% | +$399K | 2.88% | 8 |
|
|
2020
Q3 | $44.7M | Sell |
741,802
-13,181
| -2% | -$793K | 3.17% | 4 |
|
|
2020
Q2 | $44.4M | Sell |
754,983
-25,483
| -3% | -$1.52M | 3.2% | 7 |
|
|
2020
Q1 | $43.5M | Sell |
780,466
-12,117
| -2% | -$741K | 3.71% | 2 |
|
|
2019
Q4 | $50.9M | Buy |
792,583
+5,934
| +0.8% | +$340K | 3.21% | 7 |
|
|
2019
Q3 | $39.9M | Sell |
786,649
-43,103
| -5% | -$2.03M | 2.83% | 13 |
|
|
2019
Q2 | $37.6M | Sell |
829,752
-29,540
| -3% | -$1.38M | 2.62% | 13 |
|
|
2019
Q1 | $41M | Buy |
859,292
+40,474
| +5% | +$2.02M | 2.86% | 10 |
|
|
2018
Q4 | $42.6M | Sell |
818,818
-52,704
| -6% | -$2.83M | 3.22% | 8 |
|
|
2018
Q3 | $54.1M | Sell |
871,522
-1,125
| -0.1% | -$66.8K | 3.57% | 4 |
|
|
2018
Q2 | $48.3M | Buy |
872,647
+10,669
| +1% | +$576K | 3.4% | 5 |
|
|
2018
Q1 | $54.5M | Buy |
861,978
+10,822
| +1% | +$696K | 4.03% | 1 |
|
|
2017
Q4 | $52.2M | Buy |
851,156
+8,276
| +1% | +$518K | 3.61% | 1 |
|
|
2017
Q3 | $53.7M | Buy |
842,880
+19,314
| +2% | +$1.13M | 4.04% | 1 |
|
|
2017
Q2 | $45.9M | Buy |
823,566
+812,387
| +7,267% | +$44.2M | 3.55% | 4 |
|
|
2017
Q1 | $608K | Buy |
11,179
+400
| +4% | +$21.9K | 0.05% | 87 |
|
|
2016
Q4 | $630K | Sell |
10,779
-75
| -0.7% | -$4.1K | 0.05% | 93 |
|
|
2016
Q3 | $585K | Sell |
10,854
-395
| -4% | -$25.4K | 0.05% | 80 |
|
|
2016
Q2 | $827K | Sell |
11,249
-150
| -1% | -$10.6K | 0.08% | 78 |
|
|
2016
Q1 | $728K | Buy |
11,399
+570
| +5% | +$35.9K | 0.07% | 78 |
|
|
2015
Q4 | $745K | Buy |
10,829
+3,730
| +53% | +$246K | 0.07% | 83 |
|
|
2015
Q3 | $420K | Sell |
7,099
-2,176
| -23% | -$138K | 0.04% | 86 |
|
|
2015
Q2 | $617K | Sell |
9,275
-2,999
| -24% | -$198K | 0.05% | 75 |
|
|
2015
Q1 | $792K | Sell |
12,274
-2,019
| -14% | -$126K | 0.07% | 69 |
|
|
2014
Q4 | $844K | Sell |
14,293
-1,000
| -7% | -$56.4K | 0.07% | 73 |
|
|
2014
Q3 | $783K | Buy |
15,293
+5,130
| +50% | +$256K | 0.06% | 71 |
|
|
2014
Q2 | $493K | Buy |
10,163
+400
| +4% | +$19.7K | 0.04% | 86 |
|
|
2014
Q1 | $507K | Buy |
9,763
+14
| +0.1% | +$745 | 0.04% | 88 |
|
|
2013
Q4 | $518K | Sell |
9,749
-20
| -0.2% | -$1.02K | 0.05% | 81 |
|
|
2013
Q3 | $452K | Buy |
9,769
+339
| +4% | +$14.9K | 0.05% | 79 |
|
|
2013
Q2 | $421K | Buy |
+9,430
| New | +$409K | 0.04% | 80 |
|
Other funds holding BMY
RNC Capital Management's BMY Position: Q4 2025 in Review
RNC Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 7% in Q4 2025, selling an estimated $2.23M and leaving 616,326 shares worth $33.2M. The position accounts for 1.51% of the portfolio, ranked #33.
RNC Capital Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $74.3M in Q2 2022. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- RNC Capital Management held 616,326 shares of Bristol-Myers Squibb worth $33.2M as of Q4 2025.
- RNC Capital Management sold 46,351 Bristol-Myers Squibb shares in Q4 2025, an estimated $2.23M.
- Bristol-Myers Squibb made up 1.51% of RNC Capital Management's portfolio in Q4 2025, its #33 holding.
- RNC Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- RNC Capital Management's Bristol-Myers Squibb position peaked at $74.3M in Q2 2022.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.